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1108-23 Factors Affecting Regression of lschemic Mitral 
Regurgitation Following Isolated Coronary Artery 
Bypass Surgery 
Saida Z. Camowala, Nan Wang, Ramdas G. Pal, Loma Linda University Medical Center, 
Loma Linda, CA 
Backaround: Fate of ischemic mitral regurgitation (IMR) following coronary artery bypass 
surgery (CABG) alone is variable. Lack of its regression increases short and long term 
morbidity and mortality. Predictors of persistence or regression of IMR are not well 
understood. 
Methods: The prospective surgical registry at our institution was searched for patients 
undergoing CABG who also had IMR on the preoperative echocardiogram. Of the 523 
patients identified, 93 had 3r (n=65) or 4+ (n&3) IMR on a l-4 scale, and no surgical 
intervention to the mitral valve was performed. Patient characteristics: age 70210 years, 
61% male, EF 36_+14%. A postoperative echocardiogram was obtained after a mean of 
473 days following CABG. IMR grade regrewon was computed and related to clinical. 
operative and echocardiographic variables. 
Results: The mean IMR grades before and after CABG was 3.3iO.5 and 2321.2 respec- 
tively. Of the 65 patients with 3+ IMR preoperatively, 20 (31%) had 3+ and 8 (12%) had 
4+ IMR postoperatively. Of the 28 patients with 4+ preoperatw IMR. 3 (11%) and 11 
(39%) patients, respectively, had residual 3 or 4+ IMR following CABG. Regression of 
MR was significantly associated with postoperatwe reductions in LV end-diastolic (- 
5+9mm vs 2+7 mm, p=O.O06) and end-systolic (-7+_lmm vs 4+lmm, p=O.OOOS) dimen- 
sions, improvement in EF (8% vs -l%, p=O.Ol) and longer cross clamp time 
(85+38minutes vs 67$33minutes. p=O.O06) needed to correct greater number diseased 
vessels. Vascular disease elsewhere like CVA, suggesting a greater atherosclerotic bur- 
den. was associated with IMR nonregression (p=O.Ol). None of the preoperative 
echocardiographic or anglographic variables could predict IMR regression. 
Conclusions: 1) About 50% of 3-4+ IMR does not regress with CABG alone. 2) Regres- 
sion of IMR is related to LV Size reduction and function improvement secondary to myo- 
cardial revascularization. 3) Presence of myocardial viability and adequacy of 
revascularization may be critical for IMR regression following CABG alone. 
1108-24 Influence of Patch Material Stiffness on Stroke Volume 
With Surgical Anterior Ventricular Endocardial 
Restoration in lschemic Cardiomyopathy: A Finite 
Element Model Study 
Alan C. Danq, Julius M. Guccione, Robert C. German. Mark Ratcliffe, University of 
California, San Francisco, San Francisco, CA, University of Pennsylvania, Philadelphia, 
PA 
Backwound: Surgical anterior ventricular endocardial restoration (SAVER) IS a novel 
approach to the treatment of ischemic cardiomyopathy (ICM) following anterior wall inf- 
arction that excludes visibly akinetic segments of the dilated LV behind a stiff patch. The 
goal was to evaluate the effects of SAVER using a realistic mathematical model and to 
test the hypothesis that patch stiffness affects stroke volume (SV). 
Methods: A mathematical (finite element) model of LV mechanics with akinetic elements 
(contractility only 50% normal) was created from an ovine echocardiogram. The surface 
area of the akinetic region at the apex was halved, and the akinetic myocardium was 
doubled in thickness to simulate the overlap of tissue over the patch in SAVER. lmm- 
thick patches of varying stiffness from 1.2 to 500 kPa were used, where ,876 and 1.2 kPa 
reflect healthy and depressed myocardium, respectively. The model was subjected to a 
range of physiologic intraventricular pressures. A cardiac cycle with an end-systolic pres- 
sure of 1OOmmHg and end-diastolic pressure of 20mmHg was simulated. 
w: SAVER was unable to improve SV in our simulations. Depressed function, how- 
ever, is positively correlated with patch material stiffness 
The effect of patch stiffness on LV function 
End-Diastolic 
Volume (cc) 
Pre-surgical heart 56.2 
with ICM 
SAVER, C=l.Z 45.7 
kPa 
SAVER, C=lO 43.9 
kPa 
SAVER, C=50 42.3 
kPa 
SAVER, C=lOO 41.9 
kPa 
SAVER, C=500 40.9 
kPa 
End-Systolic 
Volume (cc) 
46.5 
37.0 
35.8 
35.4 
Stroke Ejection 
Volume (cc) Fraction 
9.70 17.3% 
7.70 16.8% 
6.90 15.7% 
6.50 15.4% 
6.50 15.5% 
6.40 15.6% 
1108-25 Outcomes Afler Various Surgical Strategies for Patients 
With Severe lschemic Cardiomyopathy and Moderate 
Mitral Regurgitation 
Beniamin H. Trichon, Laura P. Coombs, Christopher M. O’Connor, Mercedes Dullum, 
Eric D. Peterson, Duke Clinical Research Institute, Durham, NC, Duke University Medical 
Center, Durham, NC 
Background 
Mitral regurgitation (MA) is common among patients with LV systokc dysfunction who 
require coronary artery bypass grafting (CABG). Current strategies for treating moderate 
MR are controversial. 
Methods 
We performed a retrospective analysis of patients with LV dysfunction (EF% < 35%), and 
moderate MR undergoing CABG alone, CABG + mitral annuloplasty, CABG + mitral 
valve reconstruction, or CABG + mitral valve replacement from 1998-2001 using the 
Society of Thoracic Surgeons (STS) national database. Patients aged c: 20 years or with 
primary valve stenosis were excluded. 
Unadjusted and risk adjusted 30.day mortality rates were calculated for each of the four 
treatment strategies. 
Results 
Our study cohort included 4,173 patients. Patients undergoing valve repair or replace- 
ment in addition to CABG were older (pcO.OOOl), more likely female (p<O.OOOl) and had 
a higher EF% (pcO.0001). The outcome results are in the table below. 
There were no significant differences in 30.day mortality among patients undergoing 
CABG alone versus those receiving additional annuloplasty or mitral valve reconstruc- 
tion. Outcomes of patients undergoing annuloplasty or reconstruction were not different 
from each other (p = 0.75). Mitral valve replacement was associated with a significantly 
worse suwival at 30.days. 
Conclusions 
Among patients with ischemic cardiomyopathy and moderate MR, mitral valve annulo- 
plasty or valve reconstruction is associated with stmilar short term mortality versus CABG 
akIlls. 
Treatment (n) 30-day Mortality Adjusted OR (95% Cl) 
CABG (2700) 9.2% . . 
CABG + Ring Annuloplasty (829) 8.44% 1.16 (0.86.1.55) 
CABG + mitral valve reconstruction (169) 7.69% 1 .Ol (0x55,1.85) 
CABG + mitral valve replacement (475) 14.32% 2.28 (1.67312) 
1108-28 Delayed Revascularization Has an Adverse Effect on 
Outcome in Patients With Viable Myocardium 
Jeroen J. Bax, Arend F. Schinkel, Abdou Elhendy, Don Poldermans, Thoraxcenter 
Rotterdam, Rotterdam, The Netherlands, Leiden University Medical Center, Leiden, The 
Netherlands 
Background: Improvement in function and long-term prognosis after revascularization 
has been demonstrated in patients with ischemic cardiomyopathy and viable myocar- 
dium. However, preliminary data suggest that delayed revascularizatlon has an adverse 
effect on outcome after revascularization. The aim of the study was to evaluate the 
impact of timing of revascularization on outcome of patients with ischemic cardiomyopa- 
thy and viable myocardium. 
Methods: Consecutive patients (n=90) with ischemic cardiomyopathy and substantial 
viability (>25% of the left ventricle) on dobutamine echocardiography underwent surgical 
revascularization. Patients were divided into 2 groups: early revascularization (cl month 
of viability testing) and delayed revascularization (>l month of testing). Left ventricular 
ejection fraction (LVEF) was assessed before and 6-9 months after revascularization by 
radionuclide ventnculography. 
Results: 42 patients underwent early (23-t8 days) and 48 delayed (7&53 days) revas- 
cularization. Baseline characteristics of the 2 groups were comparable. The number of 
dysfunctional but viable segments was 5.lk3.7 in the early group and 4.9+4.1 in the 
delayed group. The number of scar segments was also comparable (3.9k3.2 versus 
3.&3.1) in the 2 groups. LVEF improved from 29*11% to 41*14% (PcO.01) in the early 
group, whereas LVEF deteriorated in the delayed group (from 28*7% to 24*12%, 
P<O.O5). No patients died before revascularization in the early group, as compared to 2 
in the delayed group. Survival at 2 years was 89% in the early group as compared to 
74% in the delayed group. 
Conclusion: delayed revascularizatkx of patients with ischemic cardiomyopathy and 
viable myocardlum is assocrated with worse outcome, as compared to early revascular- 
ization. 
Conclusions: Our results suggest that excessive patch stiffness in SAVER reduces SV 
in ICM. However, SAVER decreased SV I” all cases srmulated. TO date, this is the only 
mathematical model of SAVER and new simulations can be conducted to study other 
aspects of SAVER or other remodekng surgeries. 
